Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||
| Cash income from operating activities | 15.16%4.6M | 128.48%4M | -32.50%1.75M | 189.63%2.59M | -1.64%894.85K | 571.80%909.77K | 135.42K |
| Revenue from customers | 104.70%8.18M | 128.37%4M | -32.50%1.75M | 189.63%2.59M | -1.64%894.85K | 571.80%909.77K | --135.42K |
| Other cash income from operating activities | -199,846.48%-3.58M | --1.79K | ---- | --1 | ---- | ---- | --1 |
| Cash paid | -49.12%-8.78M | -11.32%-5.89M | 33.88%-5.29M | -60.25%-8M | -12.82%-4.99M | -89.81%-4.43M | -2.33M |
| Payments to suppliers for goods and services | -49.12%-8.78M | -11.32%-5.89M | 33.88%-5.29M | -60.25%-8M | -12.82%-4.99M | -89.81%-4.43M | ---2.33M |
| Direct interest paid | -4.69%-189.78K | 30.42%-181.27K | ---260.52K | ---- | ---- | ---- | ---- |
| Direct interest received | ---- | ---- | ---- | 9.38%-37.43K | -86.56%-41.3K | -183.85%-22.14K | --26.4K |
| Operating cash flow | -110.67%-4.37M | 45.44%-2.07M | 30.21%-3.8M | -31.59%-5.45M | -17.00%-4.14M | -61.10%-3.54M | ---2.2M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | -293.18%-459.91K | -455.00%-116.97K | 97.82%-21.08K | -272.04%-964.94K | -91.32%-259.37K | -103.01%-135.57K | 4.5M |
| Net PPE purchase and sale | -563.85%-459.91K | -356.53%-69.28K | 97.71%-15.18K | -1,500.43%-663.78K | 69.41%-41.48K | 66.59%-135.57K | ---405.72K |
| Net intangibles purchas and sale | ---- | -708.20%-47.69K | 98.04%-5.9K | -38.22%-301.16K | ---217.89K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --4.88M |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | --26.4K |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | -293.18%-459.91K | -455.00%-116.97K | 97.82%-21.08K | -272.04%-964.94K | -91.32%-259.37K | -103.01%-135.57K | --4.5M |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | 83.42%5.19M | -18.54%2.83M | -42.40%3.47M | 45.15%6.03M | 49.12%4.16M | 2.79M | |
| Net issuance payments of debt | -89.12%65.77K | 37.53%604.69K | -46.00%439.69K | --814.29K | ---- | --725K | ---- |
| Net common stock issuance | 132.20%5.27M | -26.46%2.27M | -41.04%3.09M | 23.36%5.24M | 105.88%4.24M | --2.06M | ---- |
| Net other financing activities | -63.28%-146.69K | 14.86%-89.84K | -197.52%-105.52K | 80.13%-35.47K | ---178.45K | ---- | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | 83.42%5.19M | -18.54%2.83M | -42.40%3.47M | 45.15%6.03M | 49.12%4.16M | --2.79M | ---- |
| Net cash flow | |||||||
| Beginning cash position | 137.80%1.1M | -43.23%462.15K | -31.25%814.06K | -17.21%1.18M | -38.30%1.43M | 19,175.38%2.32M | --12.03K |
| Current changes in cash | -43.53%360.62K | 283.00%638.66K | 8.46%-348.99K | -56.17%-381.26K | 72.50%-244.13K | -138.50%-887.64K | --2.31M |
| Effect of exchange rate changes | ---- | 38.68%-1.79K | 20.20%-2.92K | -86.63%-3.66K | ---1.96K | ---- | ---- |
| End cash Position | 32.81%1.46M | 137.80%1.1M | -42.17%462.15K | -32.51%799.22K | -17.21%1.18M | -38.30%1.43M | --2.32M |
| Free cash from | -120.41%-4.83M | 42.68%-2.19M | 40.38%-3.82M | -45.76%-6.41M | -19.74%-4.4M | -41.19%-3.67M | ---2.6M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |